You are here
ADLYFE, INC.
UEI: N/A
# of Employees: 10
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Development of novel methods and reagents for surveillence of prion infection
Amount: $750,000.00The prion disease process involves a conformational change in the prion protein that in turn can serve as the basis for an early detection, diagnostic, prognostic and screening assay. The Misfolded P ...
SBIRPhase II2007Department of Defense Army -
Development of a hemostatic wound dressing incorporating lyophilized platelets
Amount: $0.00Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier i ...
SBIRPhase I2005Department of Defense Army -
Development of a hemostatic wound dressing incorporating lyophilized platelets
Amount: $750,000.00Blood loss due to uncontrolled hemorrhage is a major contribution to at least 90% of the combat death before reaching the field hospital. The ability to control heavy bleeding in the injured soldier i ...
SBIRPhase II2005Department of Defense Army -
Development of novel methods and reagents for surveillence of prion infection
Amount: $100,000.00Adlyfe Inc. has developed a highly sensitive fluorescence based test, called the Misfolded Protein Diagnostic (MPD) Assay, for the misfolded prion protein associated with infectivity. The femtomolar ...
SBIRPhase I2005Department of Defense Army -
Development of a hemostatic wound dressing incorporating lyophilized platelets
Amount: $100,000.00The main goal of this proposal is to develop stabilized freeze-dried Yucatan pig platelets that will retain the majority of platelet biological properties, but can be stored in the dry state for years ...
SBIRPhase I2005Department of Defense Army -
Stabilized Platelets for Advanced Wound Healing
Amount: $99,076.00DESCRIPTION (provided by applicant): The overall goal of this Phase I proposal is to determine the resiliency of platelets during the stabilization process to co-accumulate secondary compounds to e ...
SBIRPhase I2004Department of Health and Human Services National Institutes of Health